M C Etienne - Concepedia

Author

M C Etienne

Also Known As

M C Etienne, M Etienne, M-C Etienne, M. C. ETIENNE, M. C. Etienne, M. C. Étienne, M. Etienne, M. Étienne, M.-C Etienne, M.-C. Etienne

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

Centre Antoine Lacassagne

About

M C Etienne is an author at Centre Antoine Lacassagne specializing in medicine, pharmacology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	26	1.3K
2	Biochemistry	8	8	549
3	Natural Sciences	5	5	200
4	Health Sciences	2	2	136
5	Engineering	1	1	60

M C Etienne

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Population study of dihydropyrimidine dehydrogenase in cancer patients. M C Etienne, J.-L. Lagrange, O. Dassonville, Journal of Clinical Oncology	1994	431
Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity. M C Etienne, S. Chéradame, Jean–Louis Fischel, Journal of Clinical Oncology	1995	284
Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicity G. Milano, M C Etienne, Muriel Barberi‐Heyob, British Journal of Cancer	1999	275
Influence of sex and age on fluorouracil clearance. G. Milano, M C Etienne, E. Cassuto‐Viguier, Journal of Clinical Oncology	1992	256
Correlation between dihydropyrimidine dehydrogenase activity in peripheral mononuclear cells and systemic clearance of fluorouracil in cancer patients. Ronald A. Fleming, G. Milano, Antoine Thyss, PubMed PathologyPharmacotherapyCancer PatientsOncologyPlasma Uracil Concentrations	1992	235
Known variant DPYD alleles do not explain DPD deficiency in cancer patients Elaina Collie–Duguid, M C Etienne, G. Milano, Pharmacogenetics	2000	180
Relationship between fluorouracil systemic exposure and tumor response and patient survival. G. Milano, M C Etienne, N. Renée, Journal of Clinical Oncology	1994	160
Clinical impact of pharmacokinetically-guided dose adaptation of 5-fluorouracil: results from a multicentric randomized trial in patients with locally advanced head and neck carcinomas. R. Féty, F. Rolland, Muriel Barberi‐Heyob, PubMed MedicineMetronomic TherapyPharmacologyTherapeutic ActivityDose Adaptation	1998	114
Link between dihydropyrimidine dehydrogenase activity in peripheral blood mononuclear cells and liver. M Chazal, M C Etienne, N. Renée, PubMed Pbmc-dpd ActivityPathologyOxidative StressFu ClearanceBioanalysis	1996	99
Co-variables influencing 5-fluorouracil clearance during continuous venous infusion. A NONMEM analysis M C Etienne, Étienne Chatelut, Xavier Pivot, European Journal of Cancer ThrombosisVenous Disease5-Fluorouracil ClearanceCoagulopathyContinuous Venous Infusion	1998	82

Page 1